Tag: (ASX:CSL)
Paul McKenzie to take reins as CSL’s new CEO, managing director
Global biotechnology giant CSL Limited has named Paul McKenzie as its chief executive officer and managing director, effective 6 March 2023.Â
CSL makes record 45% profit leap, takes on vaccine manufacturing
As demand for vaccines ramps up, the blood products giant has taken on the enormous task of manufacturing COVID-19 jabs – and so far,...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
